Page last updated: 2024-11-07

4-hydoxy-1-(3-pyridyl)-1-butanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

4-hydoxy-1-(3-pyridyl)-1-butanone: structure given in first source; may be metabolic product of tobacco-specific nitrosamines [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107819
CHEMBL ID17416
CHEBI ID82563
SCHEMBL ID2945748
MeSH IDM0200266

Synonyms (28)

Synonym
59578-62-0
4-hydroxy-1-(3-pyridyl)-1-butanone
4-hpb
chebi:82563 ,
CHEMBL17416
KTXUGZHJVRHQGP-UHFFFAOYSA-N
4-(3-pyridyl)-4-oxobutanol
4-hydroxy-1-pyridin-3-ylbutan-1-one
AKOS006278678
C19565
4-hydroxy-1-(3-pyridinyl)-1-butanone
FT-0670076
FT-0670074
FT-0670075
4-hydoxy-1-(3-pyridyl)-1-butanone
z79cgy64xc ,
1-butanone, 4-hydroxy-1-(3-pyridinyl)-
unii-z79cgy64xc
SCHEMBL2945748
DTXSID40208240
AS-61914
W11994
4-hydroxy-1-(pyridin-3-yl)butan-1-one
Q27156077
mfcd01320411
4-hydroxy-1-(3-pyridyl)-1-butanone (hpb)
SB84868
CS-0315776
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID22924Rate of formation of compound by F-344 rat liver microsomes1980Journal of medicinal chemistry, Nov, Volume: 23, Issue:11
Metabolic beta-hydroxylation and N-oxidation of N'-nitrosonornicotine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.55)18.7374
1990's7 (31.82)18.2507
2000's10 (45.45)29.6817
2010's4 (18.18)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]